PneumRx Acquired By BTG plc For $475M
Mountain View-based PneumRx said today that it has agreed to be acquired by BTG Plc, in a deal worth up to $475M. The developer of a minimally invasive, medical device to treat emphysema, said the deal is split between $230M upfront plus $245M in earn out. PneumRx was founded by Erin McGurk, and was venture backed by Alta Partners, Spray Venture Partners, KBL Healthcare Ventures (M. Krauss), Telegraph Hill Partners, Adams Street Partners, Forbion Capital Partners, Endeavour Vision and Silicon Valley Bank. PneumRx was advised by J.P. Morgan Securities LLC and Wilson Sonsini Goodrich & Rosati in the deal.
posted on Thursday, December 4, 2014
Related companies:
PneumRx
Related stories:
> PneumRx Buys Assets From Broncus Technologies
> PneumRx Gets $33M
> PneumRx Raises $27M
> 2Wire Acquired By Pace In $475M Deal
> Applied Materials Buys HCT Shaping Systems For $475M
silicontap.com Home